These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 18172314)
1. Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects. Chan CT; Paulmurugan R; Gheysens OS; Kim J; Chiosis G; Gambhir SS Cancer Res; 2008 Jan; 68(1):216-26. PubMed ID: 18172314 [TBL] [Abstract][Full Text] [Related]
2. Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects. Chan CT; Reeves RE; Geller R; Yaghoubi SS; Hoehne A; Solow-Cordero DE; Chiosis G; Massoud TF; Paulmurugan R; Gambhir SS Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2476-85. PubMed ID: 22895790 [TBL] [Abstract][Full Text] [Related]
3. Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors. Beebe K; Mollapour M; Scroggins B; Prodromou C; Xu W; Tokita M; Taldone T; Pullen L; Zierer BK; Lee MJ; Trepel J; Buchner J; Bolon D; Chiosis G; Neckers L Oncotarget; 2013 Jul; 4(7):1065-74. PubMed ID: 23867252 [TBL] [Abstract][Full Text] [Related]
4. Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells. Rouhi A; Miller C; Grasedieck S; Reinhart S; Stolze B; Döhner H; Kuchenbauer F; Bullinger L; Fröhling S; Scholl C Oncotarget; 2017 Jan; 8(5):7678-7690. PubMed ID: 28032595 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure--activity relationships for chimeric inhibitors of Hsp90. Shen G; Wang M; Welch TR; Blagg BS J Org Chem; 2006 Sep; 71(20):7618-31. PubMed ID: 16995666 [TBL] [Abstract][Full Text] [Related]
6. The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1. Usmani SZ; Bona RD; Chiosis G; Li Z J Hematol Oncol; 2010 Oct; 3():40. PubMed ID: 20977755 [TBL] [Abstract][Full Text] [Related]
7. Binding of p23 and hsp90 during assembly with the progesterone receptor. Johnson JL; Toft DO Mol Endocrinol; 1995 Jun; 9(6):670-8. PubMed ID: 8592513 [TBL] [Abstract][Full Text] [Related]
9. Cooperation of heat shock protein 90 and p23 in aryl hydrocarbon receptor signaling. Cox MB; Miller CA Cell Stress Chaperones; 2004 Mar; 9(1):4-20. PubMed ID: 15270073 [TBL] [Abstract][Full Text] [Related]
10. Polypeptide release by Hsp90 involves ATP hydrolysis and is enhanced by the co-chaperone p23. Young JC; Hartl FU EMBO J; 2000 Nov; 19(21):5930-40. PubMed ID: 11060043 [TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer. Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046 [TBL] [Abstract][Full Text] [Related]
12. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2. Gallerne C; Prola A; Lemaire C Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394 [TBL] [Abstract][Full Text] [Related]
14. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening. He J; Niu X; Hu C; Zhang H; Guo Y; Ge Y; Wang G; Jiang Y Protein Expr Purif; 2013 Nov; 92(1):119-27. PubMed ID: 24056254 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of macbecin as an Hsp90 inhibitor. Martin CJ; Gaisser S; Challis IR; Carletti I; Wilkinson B; Gregory M; Prodromou C; Roe SM; Pearl LH; Boyd SM; Zhang MQ J Med Chem; 2008 May; 51(9):2853-7. PubMed ID: 18357975 [TBL] [Abstract][Full Text] [Related]
16. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors. Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067 [TBL] [Abstract][Full Text] [Related]
17. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. An WG; Schulte TW; Neckers LM Cell Growth Differ; 2000 Jul; 11(7):355-60. PubMed ID: 10939589 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors. Li Z; Jia L; Wang J; Wu X; Shi G; Lu C; Shen Y Chem Biol Drug Des; 2015 Feb; 85(2):181-8. PubMed ID: 24903735 [TBL] [Abstract][Full Text] [Related]
19. Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. Li L; Wang L; You QD; Xu XL J Med Chem; 2020 Mar; 63(5):1798-1822. PubMed ID: 31663736 [TBL] [Abstract][Full Text] [Related]